Amit Akirov, MD

All articles by Amit Akirov, MD

hemodialysis in a black man

Diabetic Nephropathy

SGLT2 Inhibitors Linked to Less Renal Deterioration Across All CKD Stages

By

Amit Akirov, MD

December 10, 2019

Treatment with SGLT2 inhibitors empagliflozin and dapagliflozin may be associated with less decline in kidney function across different chronic kidney disease stages.

Next post in Diabetic Nephropathy

obese man, overweight, obesity, AUA 2017, urology, nephrology

Tx Choice for T2DM in Obese Teens Tied to Later Kidney Disease Risk